1Bristow MR.Mechanism of action of beta-blocking agents in heart failure[J].AM J Cardiol,1997,80（11A）：26L-40L.
2Yue TL,Cheng HY,Lysko PG,et al. Carvedilol,a new vasodilator and beta adrenoceptor antogonist,is an antioxidant and free radical scavenger[J].J Pharmacol Exp Ther,1992,263：92-98.
3Packer M.β-adrenergic blockade in chronic heart failure：Principles,Progress,and Practice [J].Prog Cardiovasc Dis,1998, 41（1）： 39-52.
4Flesch M,Maack C,Cremer B et al.Effect of β-blockers on free radical-induced cardiac contraction dysfunction [J].Circulation, 1999,100（4）：346-353.
5Gilbert EM,Abraham WT,Olsen S,et al. Comparative hemodynamic,left ventricular functional and anti-adrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart[J].Criculation,1996,94：2817-2828.
6Feuerstein GI,Hamburger SA,Smith EF Ⅲ,et al.Myocardiol protection with carvedilol [J].J Cardiovasc Pharmacol,1992,19（suppl 1）：S 138-141.
7Feuerstein GI,Bril A,Ruffolo RR Jr.Protective effects of carvedilol in the myocardium[J].Am J Cardiol,1997,80（11 A）：41-45.
8Yue TL,M XL,Wang X,et al.Possible involvement of stress-actived protein kinase signaling pathway and fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol[J].Cric Res,1998,82：166-174.
9Feuerstein G,Yue TL,Ma XL,et al.Novel mechanisms in the treatment of heart failure：Inhibition of oxygen radicals and apoptosis by carvedilol[J]. Prog Cardiovasc Dis,1998,41（1）:17-24.
10Packer M,Bristow R,Cohn JN,et al.The effect of carvedilol on morbidity and mortality in patients with chronic heart failure[J].N Engl J Med,1996,334：1349-1355.
